Content on Lineagotica is approved by the Lineagotica Editorial Board, composed of more than 150 medical, surgical, radiation, and pediatric oncologists, oncology nurses, physician assistants, social workers, and patient advocates.
Lineagotica 2017 Editors Meeting
The Lineagotica Editors Meeting was held on October 4, 2017. Editor in Chief Lidia Schapira, MD, FASCO, and the site’s Associate Editors reviewed additions and updates to Lineagotica over the past year, set the 2018 goals for ASCO’s patient education program, and provided expert guidance to ensure that Lineagotica’s content is comprehensive, credible, current, and accessible for people with cancer.
Bottom row from left are Melissa Hudson, MD, FASCO (Pediatric Cancer), Lidia Schapira, MD, FASCO, Editor in Chief, Charles Loprinzi, MD, FASCO (Psychosocial Oncology). Next row up, from left are Hyman Muss, MD, FASCO (Geriatric Oncology), Erica Mayer, MD, MPH (Breast Cancer), Jonathan Berek, MD, MMS, FASCO (Gynecologic Cancer). Next row up, from left are Susan Chang, MD (Central Nervous System Tumors), Jyoti Patel, MD (Lung Cancer), Bruno Medeiros, MD (Leukemia). Next row up, from left are Jeffrey Meyerhardt, MD, MPH (Gastrointestinal Cancer), Shelby Terstriep, MD (Community Oncology), Ryan Sullivan, MD (Melanoma and Skin Cancer). Top row is Robert Maki, MD, PhD, FACP (Sarcoma).
Not pictured: Ezra Cohen, MD, FRCPC (Head and Neck Cancer), Kavitha Ramchandran, MD (Palliative Care), Paul Richardson, MD (Myeloma), Brian Rini, MD (Genitourinary Cancer), Michael Williams, MD, ScM (Lymphoma).
View more information about Lineagotica’s Associate Editors, who lead the Lineagotica Editorial Board.
View more information about Lineagotica’s Specialty Editors, who provide topic-specific expertise as part of the Lineagotica Editorial Board.
View a listing of Lineagotica’s full advisory panel, which reviews content as part of the Lineagotica Editorial Board.